Introduction and objectives: Secukinumab, an antiinterleukin-17A antibody, was evaluated in phase 3 clinical studies for efficacy and safety in subjects with moderate-tosevere plaque psoriasis. This analysis evaluates the benefit on patient-reported outcome (PRO) responses of achieving improvements in objective skin clearing (as defined by PASI90 status versus PASI75 status).
Materials and methods: Patients aged ?18 years were randomized 1:1:1 in ERASURE to subcutaneous treatment groups (secukinumab 150 mg, secukinumab 300 mg, and placebo) and 1:1:1:1 in FIXTURE (including an etanercept 50 mg twice-weekly group). PRO was assessed using the Dermatology Life Quality Index (DLQI) and the visual analog scale (VAS) from the EuroQoL 5-Dimension Health Status Questionnaire (EQ-5D) at baseline and weeks 4, 8, 12, 24, 36, and 52. Subjects achieving clinical response (PASI90 or PASI75) and PRO meaningful response (DLQI (0 or1) or EQ-5D VAS (increase of at least 7 points) were compared using the chi-square test.
Results: Among the 1,144 subjects randomized to secukinumab (150 mg n = 572; 300 mg n = 572), 550 (48.3%) were PASI90 responders, and 292 (25.5%) were PASI75 responders at week 12. Subjects achieving both clinical response and DLQI response were significantly higher among the PASI90 compared with PASI75 responders at week 12 (70.0% vs 48.1%; P-value < 0.05). The response rates were similar between PASI90 and PASI75 responders (73.8% vs 70.9%; P-value > 0.05) who achieved EQ-5 D VAS response at week 12.
Conclusions: Results showed a meaningful reduction of the DLQI associated with better improvements in objective skin clearing (PASI90 versus PASI75).
Psoriasis patients with PASI90 response achieve greater health-related quality of life improvements than those with PASI75 response
Sinclair, R., McLeod, L., Mallya, UG., Fox, T., & Strober, B. (2015). Psoriasis patients with PASI90 response achieve greater health-related quality of life improvements than those with PASI75 response. Australasian Journal of Dermatology, 56(Suppl S2), 68. https://doi.org/10.1111/ajd.12337
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Meet the Experts
View All ExpertsRecent Publications
OCCASIONAL PAPER
The Preschool Entitlement
OCCASIONAL PAPER
Culturally informed community engagement
Article
Far-right and Jihadi terrorism within the United States
Article